The biology of congenital urinary bladder outflow obstruction

Congenital urinary bladder outflow obstruction (BOO) is a major cause of kidney failure in children. Sometimes, it is caused by anatomical obstruction of the urethra. In other cases, functional failure of voiding occurs without anatomical obstruction. Bladder development is driven by genes expressed in smooth muscle, neural and urothelial cell lineages. Variants in the coding regions of such genes cause a subset of BOO. In other cases, such as posterior urethral valves (PUV), noncoding variants may influence susceptibility. By modelling BOO in mutant mice, combined with viral vector mediated gene therapy, steps are being made to ameliorate the pathobiology of these diseases. Translation of such strategies to humans may require prenatal gene therapy.

Authors

Institutions

Publication Details

Journal
Trends in Molecular Medicine
Published
2025-10-01
DOI
https://doi.org/10.1016/j.molmed.2025.09.009
Primary Topic
Urological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The biology of congenital urinary bladder outflow obstruction

Melanie Chan, Adrian S. Woolf, Neil Roberts
Trends in Molecular Medicine
Urological Disorders and Treatments
article

The biology of congenital urinary bladder outflow obstruction

Melanie Chan, Adrian S. Woolf, Neil Roberts
article en

Abstract

Congenital urinary bladder outflow obstruction (BOO) is a major cause of kidney failure in children. Sometimes, it is caused by anatomical obstruction of the urethra. In other cases, functional failure of voiding occurs without anatomical obstruction. Bladder development is driven by genes expressed in smooth muscle, neural and urothelial cell lineages. Variants in the coding regions of such genes cause a subset of BOO. In other cases, such as posterior urethral valves (PUV), noncoding variants may influence susceptibility. By modelling BOO in mutant mice, combined with viral vector mediated gene therapy, steps are being made to ameliorate the pathobiology of these diseases. Translation of such strategies to humans may require prenatal gene therapy.

Trends in Molecular Medicine
Manchester Academic Health Science Centre (GB), Wellcome Centre for Cell-Matrix Research (GB), Hammersmith Hospital (GB), University of Manchester (GB), Henry Royce Institute (GB)
LifeArc, National Institute for Health and Care Research, Kidney Research UK, Rosetrees Trust, Urology Foundation, Medical Research Council
Openalex Percentile: Top 58%
Urological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.